| Smoker (n = 42) | Ex-smoker (n = 30) | None (n = 45) | P | P1 | P2 | P3 |
---|---|---|---|---|---|---|---|
Inhaled corticosteroid therapy | 26 (61.9%) | 17 (56.7%) | 10 (22.2%) | < 0.001 | 0.34 | < 0.001 | < 0.001 |
Type | Â | Â | Â | 0.01 | 0.19 | 0.02 | 0.03 |
 Budesonide | 21 (50%) | 11 (36.7%) | 6 (13.3%) |  |  |  |  |
 Beclomethazone | 5 (11.9%) | 4 (13.3%) | 3 (6.7%) |  |  |  |  |
 Fluticasone | 0 | 2 (6.7%) | 0 |  |  |  |  |
 Ciclosonide | 0 | 0 | 1 (2.2%) |  |  |  |  |
Duration (months) | 23.36 ± 13.76 | 21.93 ± 14.26 | 20.58 ± 13.78 | 0.67 | 0.44 | 0.40 | 0.95 |
Dose (equivalent to budesonide, mcg/day) | 625.45 ± 208.05 | 687.36 ± 230.09 | 566.67 ± 231.63 | 0.25 | 0.47 | 0.48 | 0.09 |
Category of doses | Â | Â | Â | 0.02 | 0.52 | 0.03 | 0.04 |
 Low | 6 (14.3%) | 5 (16.7%) | 10 (22.2%) |  |  |  |  |
 Medium | 7 (16.7%) | 2 (6.7%) | 0 |  |  |  |  |
 High | 13 (30.9%) | 10 (33.3%) | 0 |  |  |  |  |